NCCN 2012 Congress Webinar Series: Gastrointestinal Cancers™: Treatment of Local Disease and Identification of High-Risk Patients (Pancreatic Cancers)
This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Colorectal, Hepatocellular, Pancreatic, and Gastric/Esophageal Cancers. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. This series will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.
This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Explain the roles of adjuvant and neoadjuvant therapy in local pancreatic cancer
- Describe risk factors and genes involved in pancreatic cancer predisposition
Jason B. Fleming, MD
The University of Texas MD Anderson Cancer Center
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician